(Reuters) - Novartis expects to start a new study in the fourth-quarter this year.
"It will likely take until at least the end of 2008 to complete," Novartis pharma development head James Shannon said on a conference call. "And then we would propose to resubmit the dossier to the FDA sometime in mid-2009."
Read more at Reuters.com Government Filings News
"It will likely take until at least the end of 2008 to complete," Novartis pharma development head James Shannon said on a conference call. "And then we would propose to resubmit the dossier to the FDA sometime in mid-2009."
Read more at Reuters.com Government Filings News
No comments:
Post a Comment